Carbamazepine (CBZ) is one of the older antiepileptic drugs (AEDs), both in the US and
worldwide. Neurologists and non-neurologists have become very familiar with its spectrum …

Introduction: Drugs marketed during the last few years (ie Lacosamide, Ruifinamide,
Eslicarbazepine acetate, Brivaracetam and Perampanel) are increasingly regarded as third …

Cannabidiol (CBD), one of the cannabinoids from the cannabis plant, can relieve the
myotonia resulting from sodium channelopathy, which manifests as repetitive discharges of …

This paper discusses the issues surrounding the tolerability and safety of the commonly
used antiepileptic drugs (AEDs) in adolescents and adults. The content includes dose …

Introduction: Anticonvulsants that belong to the third generation are considered as
'newer'antiepileptic drugs, including: eslicarbazepine acetate, lacosamide, perampanel …

Background Eslicarbazepine acetate (ESL), a novel sodium channel blocker, is approved for
mono and adjunctive treatment of partial epileptic seizures with or without secondary …

There is currently a lack of guidance on methodology and special considerations for
transitioning patients from oxcarbazepine (OXC) or carbamazepine (CBZ) to …

Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy - Chang, XC - 2021 |
Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

This article lays the background for, and discusses the practical issues surrounding, the
adjunctive use of the last four antiepileptic drugs (AEDs) to be licensed for the treatment of …

Lacosamide is a new-generation anticonvulsant acting on Na+ channels. Compared to the
classic anticonvulsants targeting Na+ channels, lacosamide is unique in structure and in its …